The Australian Reproductive Genetic Carrier Screening Project (Mackenzie’s Mission): Design and Implementation
-
Published:2022-10-28
Issue:11
Volume:12
Page:1781
-
ISSN:2075-4426
-
Container-title:Journal of Personalized Medicine
-
language:en
-
Short-container-title:JPM
Author:
Archibald Alison D., McClaren Belinda J., Caruana JadeORCID, Tutty Erin, King Emily A., Halliday Jane L.ORCID, Best Stephanie, Kanga-Parabia Anaita, Bennetts Bruce H., Cliffe Corrina C., Madelli Evanthia O.ORCID, Ho Gladys, Liebelt Jan, Long Janet C., Braithwaite Jeffrey, Kennedy Jillian, Massie JohnORCID, Emery Jon D., McGaughran Julie, Marum Justine E., Boggs Kirsten, Barlow-Stewart Kristine, Burnett LeslieORCID, Dive LisaORCID, Freeman Lucinda, Davis Mark R., Downes Martin J.ORCID, Wallis Mathew, Ferrie Monica M., Pachter Nicholas, Scuffham Paul A.ORCID, Casella Rachael, Allcock Richard J. N., Ong Royston, Edwards SamanthaORCID, Righetti SarahORCID, Lunke SebastianORCID, Lewis Sharon, Walker Susan P., Boughtwood Tiffany F.ORCID, Hardy Tristan, Newson Ainsley J.ORCID, Kirk Edwin P., Laing Nigel G.ORCID, Delatycki Martin B.,
Abstract
Reproductive genetic carrier screening (RGCS) provides people with information about their chance of having children with autosomal recessive or X-linked genetic conditions, enabling informed reproductive decision-making. RGCS is recommended to be offered to all couples during preconception or in early pregnancy. However, cost and a lack of awareness may prevent access. To address this, the Australian Government funded Mackenzie’s Mission—the Australian Reproductive Genetic Carrier Screening Project. Mackenzie’s Mission aims to assess the acceptability and feasibility of an easily accessible RGCS program, provided free of charge to the participant. In study Phase 1, implementation needs were mapped, and key study elements were developed. In Phase 2, RGCS is being offered by healthcare providers educated by the study team. Reproductive couples who provide consent are screened for over 1200 genes associated with >750 serious, childhood-onset genetic conditions. Those with an increased chance result are provided comprehensive genetic counseling support. Reproductive couples, recruiting healthcare providers, and study team members are also invited to complete surveys and/or interviews. In Phase 3, a mixed-methods analysis will be undertaken to assess the program outcomes, psychosocial implications and implementation considerations alongside an ongoing bioethical analysis and a health economic evaluation. Findings will inform the implementation of an ethically robust RGCS program.
Funder
Australian Government’s Medical Research Future Fund as part of the Genomics Health Futures Mission the Murdoch Children’s Research Institute through Australian Genomics the National Health and Medical Research Counci the Australian Government’s Medical Research Future Fund Australian National Health and Medical Research Council Principal Research Fellowship
Subject
Medicine (miscellaneous)
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|